Suppr超能文献

获得性凝血因子Ⅴ抑制剂

Acquired Factor V Inhibitor.

作者信息

Hirai Daisuke, Yamashita Yugo, Masunaga Nobutoyo, Katsura Toshiaki, Akao Masaharu, Okuno Yoshiaki, Koyama Hiroshi

机构信息

Departmant of General Medicine, National Hospital Organization Kyoto Medical Center, Japan.

出版信息

Intern Med. 2016;55(20):3039-3042. doi: 10.2169/internalmedicine.55.6459. Epub 2016 Oct 15.

Abstract

Inhibitors directed against factor V rarely occur, and the clinical symptoms vary. We herein report the case of a patient who presented with a decreased factor V activity that had decreased to <3 %. We administered vitamin K and 6 units of fresh frozen plasma, but she thereafter developed an intracerebral hemorrhage. It is unclear whether surgery >10 years earlier might have caused the development of a factor V inhibitor. The treatment of acquired factor V inhibitors is mainly the transfusion of platelet concentrates and corticosteroids. Both early detection and the early initiation of the treatment of factor V inhibitor are thus considered to be important.

摘要

针对凝血因子V的抑制剂很少见,且临床症状各异。我们在此报告一例患者,其凝血因子V活性降低至<3%。我们给予了维生素K和6单位新鲜冰冻血浆,但此后她发生了脑出血。目前尚不清楚10多年前的手术是否可能导致了凝血因子V抑制剂的产生。获得性凝血因子V抑制剂的治疗主要是输注血小板浓缩物和使用皮质类固醇。因此,早期发现和尽早开始治疗凝血因子V抑制剂都被认为很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f488/5109576/43660fbe2fd9/1349-7235-55-3039-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验